Alaunos Therapeutics Files 2025 Annual Report Amendment
Ticker: TCRT · Form: 10-K/A · Filed: Apr 30, 2026 · CIK: 0001107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, Inc. (TCRT) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Alaunos Therapeutics filed its 2025 10-K amendment on 4/30/26. Check financials.
AI Summary
Alaunos Therapeutics, Inc. filed an amendment to its 2025 annual report on April 30, 2026. The filing, designated as a 10-K/A, pertains to the fiscal year ending December 31, 2025. The company is located at 501 E LAS OLAS BLVD SUITE 300, FORT LAUDERDALE, FL 33301.
Why It Matters
This amendment to the annual report provides updated financial and operational information for Alaunos Therapeutics for the 2025 fiscal year, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a 10-K/A filing, it indicates a potential need for correction or additional disclosure, which could signal underlying issues or complexities in the company's reporting.
Key Numbers
- 2025-12-31 — Fiscal Year End (The period covered by the annual report amendment.)
- 2026-04-30 — Filing Date (The date the amendment was accepted by the SEC.)
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Filer of the 10-K/A
- 0001107421 (company) — CIK number for Alaunos Therapeutics, Inc.
- 2025-12-31 (date) — Period of Report for the 10-K/A
- 2026-04-30 (date) — Filing Date of the 10-K/A
- 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (location) — Mailing and Business Address for Alaunos Therapeutics, Inc.
FAQ
What specific information was amended in the 10-K filing for Alaunos Therapeutics?
The provided text does not specify the exact amendments made in the 10-K/A filing; it only indicates that it is an amendment to the annual report for the period ending December 31, 2025.
What is the CIK number for Alaunos Therapeutics, Inc.?
The CIK number for Alaunos Therapeutics, Inc. is 0001107421.
When was the 10-K/A filing accepted by the SEC?
The 10-K/A filing was accepted by the SEC on April 30, 2026.
What is the business address of Alaunos Therapeutics, Inc.?
The business address of Alaunos Therapeutics, Inc. is 501 E LAS OLAS BLVD SUITE 300, FORT LAUDERDALE, FL 33301.
What industry is Alaunos Therapeutics, Inc. primarily involved in?
Alaunos Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, classified under SIC code 2834.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2026 regarding Alaunos Therapeutics, Inc. (TCRT).